Basel Medical Group Ltd
BMGLDrugs in Pipeline
13
Phase 3 Programs
4
Upcoming Catalysts
1
Next Catalyst
Mar 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Colchicine
Atrial Fibrillation
Paclitaxel dosing according to SmPC
Carcinoma, Non-Small-Cell Lung
High-dose influenza vaccine
Influenza
Vitamin D3
Improve Healthy Ageing in Seniors; Prevent Disease at Older Age
CHILD-IVITAB
Scabies
LSD
Major Depressive Disorder
Cinacalcet
Memory Functions
Salbutamol
Memory Functions
Fampridine SR
Working Memory
Dapansutrile
Diabetes Mellitus, Type 2
Interferon beta-1b group
Relapsing-remitting Multiple Sclerosis
Interferon beta 1b
Multiple Sclerosis
Vortioxetine
Glioblastoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Colchicine | Phase 3 | Atrial Fibrillation | - | - |
Paclitaxel dosing according to SmPC | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
High-dose influenza vaccine | Phase 3 | Influenza | - | - |
Vitamin D3 | Phase 3 | Improve Healthy Ageing in Seniors; Prevent Disease at Older Age | - | - |
CHILD-IVITAB | Phase 2 | Scabies | - | - |
LSD | Phase 2 | Major Depressive Disorder | - | - |
Cinacalcet | Phase 2 | Memory Functions | - | - |
Salbutamol | Phase 2 | Memory Functions | - | - |
Fampridine SR | Phase 2 | Working Memory | - | - |
Dapansutrile | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Interferon beta-1b group | Phase 2 | Relapsing-remitting Multiple Sclerosis | - | - |
Interferon beta 1b | Phase 2 | Multiple Sclerosis | - | - |
Vortioxetine | Phase 2 | Glioblastoma | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Basel Medical Group Ltd's drug pipeline?→
CatalystAlert tracks 13 drug candidates in Basel Medical Group Ltd's (BMGL) pipeline across Phase 3, Phase 2. Its lead program is Colchicine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Basel Medical Group Ltd's next FDA catalyst?→
Basel Medical Group Ltd's (BMGL) next tracked catalyst is a Phase 3 expected March 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BMGL biotech catalysts?→
Add BMGL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Basel Medical Group Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.